| Literature DB >> 31967086 |
P F Martina1,2, M Martinez3, C K Centeno2, M VON Specht1,3, J Ferreras1,2.
Abstract
INTRODUCTION: It is recognized that mobile phones may play a role in microorganism transmission and that hand hygiene, is considered the most important action for preventing infections and the spread of pathogens. The objective of this study was to determine presence and circulation bacteria on hands and mobile phones capable of causing infections in people and also determine if disinfection with gel-alcohol is useful to reduce the bacterial colonization.Entities:
Keywords: Antibiotic resistance; Bacterial contamination; Hand hygiene; Mobile phones
Mesh:
Substances:
Year: 2019 PMID: 31967086 PMCID: PMC6953443 DOI: 10.15167/2421-4248/jpmh2019.60.4.1283
Source DB: PubMed Journal: J Prev Med Hyg ISSN: 1121-2233
Minimum inhibitory concentration in bacteria antibiotic resistant recovered in this study.
| Species - isolated | OXA | GEN | ERI | NIT | SXT | AMP | SAM | TZP | CF | CTX | CAZ | CEF | IPM | MEM | NAL | COL | AZT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ≥ 8 | 64 | - | |||||||||||||||
| 4 | ≥ 8 | - | |||||||||||||||
| ≥ 4 | ≥ 8 | - | |||||||||||||||
| ≥ 4 | ≥ 320 | - | |||||||||||||||
| 64 | 10 | - | |||||||||||||||
| 64 | 10 | - | |||||||||||||||
| ≥ 16 | 256 | ≥ 32 | ≥ 16 | ||||||||||||||
| P. | ≥ 512 | 80 | ≥ 32 | ≥ 32 | 32 | 16 | ≥ 32 | - | |||||||||
| ≥ 512 | 80 | ≥ 32 | ≥ 32 | 32 | 16 | ≥ 32 | - | ||||||||||
| 512 | 16 | 8 | - | ||||||||||||||
| 256 | ≥ 32 | 4 | 8 | 16 | - | ||||||||||||
| 256 | ≥ 32 | 16 | ≥ 64 | ≥ 16 | - | ||||||||||||
| 256 | ≥ 32 | 16 | ≥ 64 | ≥ 16 | - | ||||||||||||
| ≥ 16 | ≥ 16 | ≥ 16 | ≥ 32 | ||||||||||||||
| 2 | - | ||||||||||||||||
| 256 | ≥ 32 | ≥ 32 | ≥ 128 | ≥ 64 | ≥ 64 | 32 | - |
OXA, oxalin; GEN, gentamicin; ERI, erythromycin; NIT, nitrofurantoin; SXT, trimethoprim/sulfamethoxazole; AMP, ampicillin, SAM, Ampicillin/Sulbactam; TZP, Piperacillin/Tazobactam; CF, cefalotin; CTX, cefotaxime; CAZ, ceftazidime; CEF, cefepime; IPM, imipenem, MEM, meropenem, NAL, nalidic acid; COL, colistin; AZT, azteronam. (- ) no tested
* Intermed according to CLSI [7].
Determination of minimal inhibition concentration in Gram positive bacteria recovered in this study.
| Antibiotic | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oxacilin | 0.5 | S | 0.5 | S | 0.25 | S | 4 | R | 4 | R | 2 | S | 2 | S | - | - | - | - | - | - | - | - |
| Gentamicin | 0.5 | S | 0.5 | S | 4 | R | 0.5 | S | 0.5 | S | - | - | - | - | - | - | - | - | - | - | - | - |
| Ciprofloxacin | 0.5 | S | 0.5 | S | 0.5 | S | 0.5 | S | 0.5 | S | - | - | - | - | - | - | - | - | - | - | - | - |
| Levofloxacin | 1 | S | 0.5 | S | 0.12 | S | 0.5 | S | 1 | S | 0.5 | S | 0.5 | S | 0.5 | S | 0.5 | S | 0.5 | S | 0.5 | S |
| Moxifloxacin | 0.25 | S | 0.25 | S | 0.25 | S | 0.25 | S | 0.25 | S | 0.5 | S | 0.5 | S | - | - | - | - | - | - | - | - |
| Erythromycin | ≥ 8 | R | 0.5 | S | 8 | R | 0.5 | S | 8 | R | 0.25 | S | 0.25 | S | - | - | - | - | - | - | - | - |
| Clindamycin | 0.25 | S | 0.25 | S | 0.25 | S | 0.25 | S | 0.25 | S | - | - | - | - | 2 | I | 1 | I | 0.5 | S | - | - |
| Quinupristin/Dalfopristin | 1 | S | 0.5 | S | 0.5 | S | 1 | S | 0.5 | S | 1 | S | 1 | S | - | - | - | - | - | - | - | - |
| Linezolid | 4 | S | 2 | S | 2 | S | 4 | S | 4 | S | 2 | S | 2 | S | - | - | - | - | - | - | - | - |
| Teicoplanin | 4 | S | 4 | S | 0.5 | S | 4 | S | 0.5 | S | 0.5 | S | 0.5 | S | - | - | - | - | - | - | - | - |
| Vancomycin | 1 | S | 1 | S | 1 | S | 1 | S | 1 | S | 0.5 | S | 0.5 | S | 0.25 | S | 0.25 | S | 0.25 | S | 1 | S |
| Minocycline | 0.5 | S | 0.5 | S | 0.5 | S | 0.5 | S | 0.5 | S | 0.5 | S | 0.5 | S | - | - | - | - | - | - | - | - |
| Tetracycline | 2 | S | 1 | S | 1 | S | 1 | S | 1 | S | 1 | S | 1 | S | - | - | - | - | - | - | - | - |
| Nitrofurantoin | 64 | I | 32 | S | 16 | S | 16 | S | 16 | S | 64 | I | 64 | I | - | - | - | - | - | - | - | - |
| Rifampicin | 0.5 | S | 0.5 | S | 0.5 | S | 0.5 | S | 0.5 | S | - | - | - | - | - | - | - | - | - | - | - | - |
| Trimethoprim/Sulfamethoxazole | 10 | S | 10 | S | 10 | S | 320 | R | 10 | S | 10 | R | 10 | R | - | - | - | - | - | - | - | - |
(- ) no tested. S, sencible. I, intermed. R, resistant according to CLSI [7].
Determination of minimal inhibition concentration in Gram negative bacteria recovered in this study.
| Antibiotic | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ampicillin | 2 | S | ≥ 32 | R | ≥ 32 | R | 16 | R | 16 | R | 32 | R | 32 | R | - | - | 2 | R | ≥ 32 | R |
| Ampicillin/Sulbactam | 2 | S | ≥ 32 | R | ≥ 32 | R | 2 | S | 2 | S | 16 | R | 16 | R | - | - | 2 | S | ≥ 32 | R |
| Piperacillin/Tazobactam | 4 | S | 32 | I | 32 | I | 4 | S | 4 | S | 4 | S | 4 | S | - | - | 4 | S | ≥ 128 | I |
| Cefalotin | 64 | R | 64 | R | - | - | 2 | S | ||||||||||||
| Cefotaxime | 1 | S | 16 | R | 16 | R | 8 | R | 8 | R | 1 | S | 1 | S | - | - | 1 | S | ≥ 64 | I |
| Ceftazidime | 4 | S | 4 | S | 4 | S | 4 | S | 1 | S | 1 | S | 4 | S | 1 | S | ≥ 64 | S | ||
| Cefepime | 4 | S | 1 | S | 1 | S | 2 | S | 2 | S | 1 | S | 1 | S | - | - | 1 | S | 32 | S |
| Imipenem | 1 | S | 1 | S | 0.25 | S | 0.25 | S | 0.5 | S | 0.5 | S | ≥ 16 | R | 0.25 | S | 1 | S | ||
| Meropenem | 4 | S | 1 | S | 1 | S | 0.25 | S | 0.25 | S | 0.25 | S | 0.25 | S | ≥ 16 | R | 0.25 | S | 1 | S |
| Amikacim | 2 | S | 2 | S | 2 | S | 2 | S | 2 | S | 2 | S | 2 | S | 2 | S | 16 | S | ||
| Gentamicin | 16 | R | 1 | S | 1 | S | 1 | S | 1 | S | 1 | S | 1 | S | ≥ 16 | R | 1 | S | 2 | S |
| Nalidixic acid | 32 | R | ≥ 32 | R | ≥ 32 | R | 2 | S | 2 | S | 2 | S | 2 | S | - | - | 2 | S | 4 | R |
| Ciprofloxacin | 1 | S | 0.25 | S | 0.25 | S | 0.25 | S | 0.25 | S | 0.25 | S | 0.25 | S | - | - | 0.25 | S | 0.25 | S |
| Nitrofurantoin | 256 | R | 512 | R | 512 | R | 512 | R | 512 | R | 256 | R | 128 | R | - | - | 32 | S | 256 | R |
| Colistin | - | - | 0.5 | S | 0.5 | S | 0.5 | S | 0.5 | S | 16 | R | 16 | R | - | - | 0.5 | S | ||
| Trimethoprim/Sulfamethoxazole | - | - | 80 | R | 80 | R | 20 | S | 20 | S | 20 | S | 20 | S | 20 | S | 20 | S | ≤ 20 | S |
| Levofloxacin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2 | S | - | - | - | - |
| Minocycline | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ≤ 4 | S | - | - | - | - |
| Aztreonam | ≥ 16 | R | - | - | - | - | - | - | - | - | - | - | - | - | ≥ 32 | R | - | - | - | - |
(- ) no tested; () no detected. S, sensitive. I, intermed. R, resistent according to CLSI [7].